Negative evidences in association between apolipoprotein E polymorphism and panic disorder

European Psychiatry

Volumn 21, Issue 1, 2006, Pages 59-61

  Martinez Barrondo S ^a   Saiz P A ^a   Morales, B ^b   Garcia Portilla M P ^a   Coto, E ^b   Alvarez V ^b   Bascaran M T ^a   Bousono M ^a   Bobes, J ^a  

^a UNIVERSIDAD DE OVIEDO   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Apolipoprotein E; Genetic association; Panic disorder

Indexed keywords

APOLIPOPROTEIN E;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANIC; PRIORITY JOURNAL;

ADULT; APOLIPOPROTEINS E; FEMALE; GENE FREQUENCY; HUMANS; MALE; PANIC DISORDER; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 32644449630     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2005.04.012     Document Type: Article

References (22)

1. M.Y. Agargun, E. Algun, R. Sekeroglu, H. Kara, and M. Tarakcioglu Low cholesterol levels in patients with panic disorder: the association with major depression J. Affect. Disord. 50 1998 29 32
2. M.Y. Agargun, H. Kara, E. Algun, R. Sekeroglu, and M. Tarakcioglu High cholesterol levels in patients with sleep panic Biol. Psychiatry 40 1996 1064 1065
3. W.K. Bajwa, G.M. Asnis, W.C. Sanderson, A. Irfan, and H.M. van Praag High cholesterol levels in patients with panic disorder Am. J. Psychiatry 149 1992 376 378
4. C.N. Bassett, and T.J. Montine Lipoproteins and lipid peroxidation in Alzheimer's disease J. Nutr. Health Aging 7 2003 24 29
5. K. Dantendorfer, D. Prayer, J. Kramer, M. Amering, W. Baischer, and P. Berger High frequency of EEG and MRI brain abnormalities in panic disorder Psychiatry Res. 68 1996 41 53
6. R. Feder High cholesterol levels in patients with panic disorder Am. J. Psychiatry 150 1993 527
7. C. Hayward, C.B. Taylor, W.T. Roth, R. King, and W.S. Agras Plasma lipid levels in patients with panic disorder or agoraphobia Am. J. Psychiatry 146 1989 917 919
8. G. Massana, J.M. Serra-Grabulosa, P. Salgado-Pineda, C. Gasto, C. Junque, J. Massana, and J.M. Mercader Parahippocampal gray matter density in panic disorder: a voxel-based morphometric study Am. J. Psychiatry 160 2003 566 568
9. M. Michikawa The role of cholesterol in pathogenesis of Alzheimer's disease: dual metabolic interaction between amyloid beta-protein and cholesterol Mol. Neurobiol. 27 2003 1 12
10. J.D. Morrow, K. McManus, G.R. Tait, F. Bellavance, W. Chrapko, and N. Lara Pentagastrin-induced release of free fatty acids in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol J. Psychiatry Neurosci. 28 2003 127 133
11. G.I. Papakostas, D. Öngür, D.V. Iosifescu, D. Mischoulon, and M. Fava Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses Eur. Neuropsychopharmacol. 14 2004 135 142
12. S.S. Petanceska, S. DeRosa, A. Sharma, N. Diaz, K. Duff, and S.G. Tint Changes in a apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol Mol. Neurosci. 20 2003 395 406
13. R.E. Pitas, J.K. Boyles, S.H. Lee, D. Hiu, and K.H. Weisgraber Lipoproteins and their receptors in the central nervous system J. Biol. Chem. 262 1987 14352 14360
14. L. Puglielli, R.E. Tanzi, and D.M. Kovacs Alzheimer's disease: the cholesterol connection Nat. Neurosci. 6 2003 345 351
15. P.A. Sáiz, B. Morales, M.P. G-Portilla, V. Álvarez, E. Coto, and J.M. Fernández Apolipoprotein E genotype and schizophrenia: further negative evidence Acta Psychiatr. Scand. 105 2002 71 75
16. T. Shiori, K. Fujii, T. Someya, and S. Takahashi Frequency distribution of serum cholesterol levels in patients with panic disorder: comparison with normal controls Psychiatry Clin. Neurosci. 52 1998 601 604
17. T. Shioiri, K. Fujii, T. Someya, and S. Takahashi Serum cholesterol levels and panic symptoms in patients with panic disorder: a preliminary study J. Affect. Disord. 58 2000 167 170
18. M.E. Tancer, M.B. Stein, D.E. Moul, and T.W. Uhde Normal serum cholesterol in panic disorder Biol. Psychiatry 27 1990 99 101
19. K. Tsukamoto, R.K. Tangirala, S. Chun, D. Usher, E. Pure, and D.J. Rader Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice Mol. Ther. 1 2000 189 194
20. E.J. Weeber, U. Beffert, C. Jones, J.M. Christian, E. Forster, and J.D. Sweatt Reelin in ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning J. Biol. Chem. 277 2002 39944 39952
21. P.R. Wenham, W.H. Price, and G. Blandell Apolipoprotein E genotyping by one-stage PCR Lancet 337 1991 1158 1159
22. World Medical Association. Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subject. Amended by 41st World Medical Assembly, Hong Kong, 1989.